Glenview Capital Management Buys Cigna Corp, Shire PLC, DXC Technology Co, Sells Express Scripts Holding Co, Aetna Inc, Allergan PLC

• New Purchases: BAX, HUM, LTHM,
• Added Positions: CI, SHPG, DXC, GOOGL, CVS, HCA, HOLX, FDC, BHC, LYB, FMC, BKD, NVT, IQV, DLPH, WMB, CNDT,
• Reduced Positions: AGN, FDX, TMO, ARMK, WBA, EBAY, ENDP, ANTM, UHS, DWDP, NXPI, ABC, NUAN, MCK, LOW, ESI, VER, FLEX, LBTYA, MSFT, LBTYK, APTV, CBS, HTZ, MTOR,
• Sold Out: ESRX, AET, CHTR, SYMC, FBHS, DLTR, WP, MHK, MIK, LH,

For the details of Larry Robbins's stock buys and sells, go to https://www.gurufocus.com/guru/larry+robbins/current-portfolio/portfolio

1. Shire PLC (SHPG) - 4,563,127 shares, 7.69% of the total portfolio. Shares added by 55.63%
2. FMC Corp (FMC) - 8,912,854 shares, 6.38% of the total portfolio. Shares added by 4.53%
3. IQVIA Holdings Inc (IQV) - 5,362,932 shares, 6.03% of the total portfolio. Shares added by 1.25%
4. HCA Healthcare Inc (HCA) - 4,898,569 shares, 5.90% of the total portfolio. Shares added by 13.00%
5. CVS Health Corp (CVS) - 8,489,991 shares, 5.39% of the total portfolio. Shares added by 28.35%

Glenview Capital Management initiated holding in Baxter International Inc. The purchase prices were between $61.45 and $77.3, with an estimated average price of $66.9. The stock is now traded at around $76.51. The impact to a portfolio due to this purchase was 0.56%. The holding were 877,001 shares as of .

Glenview Capital Management initiated holding in Humana Inc. The purchase prices were between $273.36 and $353.98, with an estimated average price of $315.97. The stock is now traded at around $279.82. The impact to a portfolio due to this purchase was 0.51%. The holding were 185,195 shares as of .

Glenview Capital Management initiated holding in Livent Corp. The purchase prices were between $12.3 and $19.17, with an estimated average price of $16.28. The stock is now traded at around $12.09. The impact to a portfolio due to this purchase was 0.2%. The holding were 1,519,910 shares as of .

Glenview Capital Management added to a holding in Cigna Corp by 177.24%. The purchase prices were between $178.01 and $224.84, with an estimated average price of $208.27. The stock is now traded at around $169.56. The impact to a portfolio due to this purchase was 3.2%. The holding were 2,718,586 shares as of .

Glenview Capital Management added to a holding in Shire PLC by 55.63%. The purchase prices were between $166.22 and $181.95, with an estimated average price of $174.76. The stock is now traded at around $179.20. The impact to a portfolio due to this purchase was 2.75%. The holding were 4,563,127 shares as of .

Glenview Capital Management added to a holding in DXC Technology Co by 92.55%. The purchase prices were between $50.03 and $93.67, with an estimated average price of $68.13. The stock is now traded at around $65.32. The impact to a portfolio due to this purchase was 2.28%. The holding were 9,213,636 shares as of .

Glenview Capital Management added to a holding in Alphabet Inc by 42.40%. The purchase prices were between $984.67 and $1211.53, with an estimated average price of $1076.53. The stock is now traded at around $1192.53. The impact to a portfolio due to this purchase was 1.34%. The holding were 446,051 shares as of .

Glenview Capital Management added to a holding in CVS Health Corp by 28.35%. The purchase prices were between $62.92 and $80.8, with an estimated average price of $74.46. The stock is now traded at around $55.88. The impact to a portfolio due to this purchase was 1.19%. The holding were 8,489,991 shares as of .

Glenview Capital Management added to a holding in Bausch Health Companies Inc by 86.72%. The purchase prices were between $17.64 and $28.32, with an estimated average price of $23.64. The stock is now traded at around $24.14. The impact to a portfolio due to this purchase was 0.55%. The holding were 6,590,308 shares as of .

Glenview Capital Management sold out a holding in Express Scripts Holding Co. The sale prices were between $91.99 and $101.47, with an estimated average price of $96.61.

Glenview Capital Management sold out a holding in Aetna Inc. The sale prices were between $195.13 and $212.7, with an estimated average price of $203.61.

Glenview Capital Management sold out a holding in Charter Communications Inc. The sale prices were between $273.52 and $330.33, with an estimated average price of $312.92.

Glenview Capital Management sold out a holding in Symantec Corp. The sale prices were between $17.68 and $23.32, with an estimated average price of $20.66.

Glenview Capital Management sold out a holding in Fortune Brands Home & Security Inc. The sale prices were between $35.96 and $53.26, with an estimated average price of $43.91.

Glenview Capital Management sold out a holding in Dollar Tree Inc. The sale prices were between $79.51 and $90.32, with an estimated average price of $84.47.

Glenview Capital Management reduced to a holding in Allergan PLC by 87.92%. The sale prices were between $129.82 and $193.46, with an estimated average price of $162.67. The stock is now traded at around $149.80. The impact to a portfolio due to this sale was -1.77%. Glenview Capital Management still held 200,971 shares as of .

Glenview Capital Management reduced to a holding in FedEx Corp by 74.44%. The sale prices were between $152.7 and $240.94, with an estimated average price of $210.41. The stock is now traded at around $179.08. The impact to a portfolio due to this sale was -1.61%. Glenview Capital Management still held 360,551 shares as of .

Glenview Capital Management reduced to a holding in Thermo Fisher Scientific Inc by 46.75%. The sale prices were between $208.47 and $251.98, with an estimated average price of $234.12. The stock is now traded at around $261.43. The impact to a portfolio due to this sale was -1.6%. Glenview Capital Management still held 1,176,841 shares as of .

Glenview Capital Management reduced to a holding in Aramark by 63.81%. The sale prices were between $27.5 and $42.27, with an estimated average price of $35.76. The stock is now traded at around $29.86. The impact to a portfolio due to this sale was -1.45%. Glenview Capital Management still held 3,022,359 shares as of .

Glenview Capital Management reduced to a holding in Walgreens Boots Alliance Inc by 75.18%. The sale prices were between $65.26 and $85.69, with an estimated average price of $77.55. The stock is now traded at around $61.82. The impact to a portfolio due to this sale was -1.35%. Glenview Capital Management still held 961,747 shares as of .

Glenview Capital Management reduced to a holding in eBay Inc by 37.87%. The sale prices were between $26.14 and $33.28, with an estimated average price of $29.29. The stock is now traded at around $36.35. The impact to a portfolio due to this sale was -0.92%. Glenview Capital Management still held 7,192,991 shares as of .